-transparent.png){kind=logo}
Viskaldix, a combination of Pindolol (Visken)--10 mg with Clopamide--5 mg, was administered to 15 patients with arterial hypertension. The follow up of the patients was according to a previous plan, the preparation administered according, to a schedule. In the determination of the stage of the disease, consideration was mainly given to the values of the diastolic pressure, measured in a lying position. The patients examined were of the following age: to 40--I patient; to 50-7 patients; to 60--7 patients. Seven patients were at the stage I, 4 patients--stage OII and 4 patients--stage III. Reduction of systolic and diastolic pressure with more than 1.33 kPa (10 mm Hg column) both in a lying and standing position were recorded in 2/3 of the patients with the treatment carried out. The effect on the blood pressure, was noticed to develop in 1/3 of the patients with the administration of 2 tablets daily. The blood pressure of only one patient failed to respond to the treatment.
N Radeva, and
V Pasheva, and
Ch Nachev
January 1984,
Kardiologia polska,
N Radeva, and
V Pasheva, and
Ch Nachev
January 1984,
Lijecnicki vjesnik,
N Radeva, and
V Pasheva, and
Ch Nachev
January 1987,
Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
N Radeva, and
V Pasheva, and
Ch Nachev
January 1986,
Kardiologia polska,
N Radeva, and
V Pasheva, and
Ch Nachev
January 1984,
Lijecnicki vjesnik,
N Radeva, and
V Pasheva, and
Ch Nachev
October 1988,
Klinicheskaia meditsina,
N Radeva, and
V Pasheva, and
Ch Nachev
January 1984,
Lijecnicki vjesnik,
N Radeva, and
V Pasheva, and
Ch Nachev
October 1978,
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
N Radeva, and
V Pasheva, and
Ch Nachev
April 1981,
The Practitioner,
N Radeva, and
V Pasheva, and
Ch Nachev
November 1983,
Polski tygodnik lekarski (Warsaw, Poland : 1960),
